Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 14, 2025
Reporting Period: The filing incorporates by reference financial results for the first quarter and the three-month period ended March 31, 2025 (Exhibit 99.1). The filing itself serves as a vehicle to distribute a press release dated May 14, 2025 (Exhibit 99.2).
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific numerical data. It references Exhibit 99.1 for financial results but does not list values for:
- Revenue
- Profit or Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric; these are contained in the referenced exhibits not included in the input.
Material Changes
The filing text does not describe specific material changes versus prior periods. It indicates that financial results for the period ended March 31, 2025, are available in Exhibit 99.1, but the specific variances or trends are not detailed in the provided content.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.2) dated May 14, 2025. However, the content of this press release, including any guidance, outlook, or management commentary, is not present in the input text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual financial results for the quarter ended March 31, 2025, as the cover sheet contains no numbers.
- Read Exhibit 99.2 (Press Release) for management's commentary, strategic updates, and any forward-looking statements.
- Verify the incorporation by reference into Registration Statements No. 333-268885 and 333-280606.
- Confirm that the press release information is furnished and not deemed "filed" under Section 18 of the Exchange Act, limiting liability exposure.